High-recovery visual identification and single-cell retrieval of circulating tumor cells for genomic analysis using a dual-technology platform integrated with automated immunofluorescence staining
Campton, Daniel E, Ramirez, Arturo B, Nordberg, Joshua J, Drovetto, Nick, Clein, Alisa C, Varshavskaya, Paulina, Friemel, Barry H, Quarre, Steve, Breman, Amy, Dorschner, Michael, Blau, Sibel, Blau, C Anthony, Sabath, Daniel E, Stilwell, Jackie L, Kaldjian, Eric P
Published in BMC cancer (06.05.2015)
Published in BMC cancer (06.05.2015)
Get full text
Journal Article
Impact of Exigent Research Network’s partnership with the Tempus AI TIME Program on the screening and matching of patients for clinical trials
Gajra, Ajeet, Mallahan, Samantha, Blau, Sibel, Peguero, Julio Antonio, Shoukier, Mahran, Kanaan, Mohamad, Huynh, Chanh Trung, Efiom-Ekaha, Daniel N., Vankayala, Hema M., Kitchen, Kyle, Kendall, Stephan Disean, Orsini, James Michael, Babu, Sunil, Hellyer, Jessica, Weart, Thomas, Meyer, Janelle Marie, Clifford, Christian, Skelly, Danielle, Patnaude, Emily, Cooney, Matthew M.
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Abstract PD13-03: Ribociclib, everolimus, exemestane triplet therapy in HR+/HER2− advanced breast cancer after progression on a CDK4/6 inhibitor: Final efficacy, safety, and biomarker results from TRINITI-1
Hurvitz, Sara A., Clark, Amy S., Rugo, Hope S., Bardia, Aditya, Zelnak, Amelia, Yardley, Denise A., Karuturi, Meghan, Sanft, Tara, Blau, Sibel, Hart, Lowell, Ma, Cynthia, Purkayastha, Das, Eppig, Colleen, DeMichele, Angela
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Get full text
Journal Article
Phase I/II trial of triplet therapy (exemestane, ribociclib, and everolimus) after progression on a CDK4/6 inhibitor in HR+/HER2– advanced breast cancer (TRINITI-1)
Bardia, Aditya, Hurvitz, Sara A., DeMichele, Angela, Clark, Amy S., Zelnak, Amelia, Yardley, Denise A., Karuturi, Meghan, Sanft, Tara, Blau, Sibel, Hart, Lowell, Ma, Cynthia, Rugo, Hope S., Purkayastha, Das, Moulder, Stacy
Published in Clinical cancer research (15.03.2021)
Published in Clinical cancer research (15.03.2021)
Get full text
Journal Article
Operational metrics for the ELAINE II study combining a traditional approach with a just-in-time model
Blau, Sibel, Peguero, Julio Antonio, Moore, Halle C. F., Anderson, Ian Churchill, Barve, Minal A., Cherian, Mathew Amprayil, Elkhanany, Ahmed, O'Sullivan, Ciara Catherine Maria, Moreno-Aspitia, Alvaro, Plourde, Paul, Gleich, Lyon L., Riesen, Kendra, Ezzati, Ross, Degele, Meghan, Shulman, Megan, Stempf, Stephanie, Cooney, Matthew M., Damodaran, Senthil
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Complications and severity of COVID-19 in patients with head and neck cancer (HNC): A COVID-19 and Cancer Consortium (CCC19) registry analysis
Karivedu, Vidhya, Hsu, Chih-Yuan, Deeken, John F., Jhawar, Sachin R, Stover, Daniel G., Bowles, Daniel W., Hwang, Clara, McKay, Rana R., Ruiz-Garcia, Erika, Bakouny, Ziad, Sabbah, Arielle, Klein, Elizabeth, Yu, Peter Paul, Glover, Michael, Wotman, Michael, Durbin, Eric B., Kulkarni, Amit, Blau, Sibel, Hallmeyer, Sigrun, Wise-Draper, Trisha Michel
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Everolimus Plus Exemestane vs Everolimus or Capecitabine Monotherapy for Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer: The BOLERO-6 Randomized Clinical Trial
Jerusalem, Guy, de Boer, Richard H, Hurvitz, Sara, Yardley, Denise A, Kovalenko, Elena, Ejlertsen, Bent, Blau, Sibel, Özgüroglu, Mustafa, Landherr, László, Ewertz, Marianne, Taran, Tetiana, Fan, Jenna, Noel-Baron, Florence, Louveau, Anne-Laure, Burris, Howard
Published in JAMA oncology (01.10.2018)
Published in JAMA oncology (01.10.2018)
Get more information
Journal Article
Characteristics of a Comprehensive, Continuously Updated Longitudinal Database for Multiple Myeloma
Blau, C. Anthony, Nam, Grace, Chhun, Leena, Zheng, Cheng, Piboonvaranggoon, Jayne, Wren, Jennifer, Mallick, Elora, Zelko, Lauren, Wolcott, Michiko, Lopez, Carmen, Namburi, Swathi, Blau, Sibel, Senecal, Francis M., McCroskey, Robert, Moezi, Mehdi M., Ayed, Ayed O., Lopez Barquilla, Ricardo, Richter, Joshua, Bensinger, William I., Richardson, Paul G., Anderson, Kenneth C.
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Leveraging machine learning technology to efficiently identify and match patients for precision oncology clinical trials
Sachse, Laura, Dasari, Smriti, Ackermann, Marc, Patnaude, Emily, OLeary, Stephanie, Al-Olimat, Hussein, Grigorenko, Alexander, Stewart, Andrew, Ward, AnnaJane, Darmofal, Annie, Ballakur, Sowmya, Bennett, William, Franzen, Amy, Blau, Sibel, Chandra, Abhinav Binod, Nikolinakos, Petros, Orsini, James Michael, Peguero, Julio Antonio, Blackwell, Kimberly L., Cooney, Matthew M.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Augmented intelligence to predict 30-day mortality in patients with cancer
Gajra, Ajeet, Zettler, Marjorie E, Miller, Kelly A, Blau, Sibel, Venkateshwaran, Swetha S, Sridharan, Shreenath, Showalter, John, Valley, Amy W, Frownfelter, John G
Published in Future oncology (London, England) (01.10.2021)
Published in Future oncology (London, England) (01.10.2021)
Get full text
Journal Article
Abstract PS11-13: Multidimensional molecular profiling of repeated metastatic TNBC biopsies in the intensive trial of omics safely guides treatment decisions
Burton, Kimberly A, Konnick, Eric Q, Blau, Sibel, Dorschner, Michael O, Gralow, Julie, Parulkar, Rahul, Mahen, Elisabeth, Spilman, Patricia, Parker, Stephanie, Senecal, Francis M, Pritchard, Colin, Szeto, Christopher, Zhu, Jing, Gadi, Vijayakrishna K, Benz, Stephen C, Rabizadeh, Shahrooz, Soon-Shiong, Patrick, Blau, Carl Anthony
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Get full text
Journal Article
Variation in the Treatment of Multiple Myeloma in the Real World
Richter, Joshua, Chhun, Leena, Zheng, Cheng, Piboonvaranggoon, Jayne, Mallick, Elora, Wren, Jennifer, Nam, Grace, Lopez Barquilla, Ricardo, Dardac, Alexandra, Blau, Sibel, Senecal, Francis M., Namburi, Swathi, Cowan, Andrew J., Bensinger, William I, Kumar, Shaji K., Richardson, Paul G., Anderson, Kenneth, Blau, C. Anthony
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Triplet therapy (continuous ribociclib, everolimus, exemestane) in HR+/HER2− advanced breast cancer postprogression on a CDK4/6 inhibitor (TRINITI-1): Efficacy, safety, and biomarker results
Bardia, Aditya, Hurvitz, Sara A., DeMichele, Angela, Clark, Amy Sanders, Zelnak, Amelia Bruce, Yardley, Denise A., Karuturi, Meghan Sri, Sanft, Tara B., Blau, Sibel, Hart, Lowell L., Ma, Cynthia X., Caria, Nicola, Purkayastha, D. Das, Mistry, Alomi, Moulder, Stacy L.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Letrozole + ribociclib versus letrozole + placebo as neoadjuvant therapy for ER+ breast cancer (FELINE trial)
Khan, Qamar J., O'Dea, Anne, Bardia, Aditya, Kalinsky, Kevin, Wisinski, Kari Braun, O'Regan, Ruth, Yuan, Yuan, Ma, Cynthia X., Jahanzeb, Mohammad, Trivedi, Meghna S., Spring, Laura, Makhoul, Issam, Wagner, Jamie L., Winblad, Onalisa, Amin, Amanda Leigh, Blau, Sibel, Crane, Gregory James, Elia, Manana, Hard, Mia, Sharma, Priyanka
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Abstract P4-01-21: Analysis and single-cell retrieval of circulating tumor cells to monitor treatment response and assess genotype in triple-negative breast cancer
Ramirez, Arturo, Campton, Daniel, Mahen, Elisabeth, Blau, Sibel, Blau, Anthony, Kaldjian, Eric, Stilwell, Jackie
Published in Cancer research (Chicago, Ill.) (01.05.2015)
Published in Cancer research (Chicago, Ill.) (01.05.2015)
Get full text
Journal Article
BRCA2 Reversion Mutation Associated With Acquired Resistance to Olaparib in Estrogen Receptor-positive Breast Cancer Detected by Genomic Profiling of Tissue and Liquid Biopsy
Gornstein, Erica L., Sandefur, Sara, Chung, Jon H., Gay, Laurie M., Holmes, Oliver, Erlich, Rachel L., Soman, Salil, Martin, L. Katherine, Rose, Andrea V., Stephens, Philip J., Ross, Jeffrey S., Miller, Vincent A., Ali, Siraj M., Blau, Sibel
Published in Clinical breast cancer (01.04.2018)
Published in Clinical breast cancer (01.04.2018)
Get full text
Journal Article
Everolimus (EVE) + exemestane (EXE) vs EVE alone or capecitabine (CAP) for estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC): BOLERO-6, an open-label phase 2 study
Jerusalem, Guy Heinrich Maria, Kovalenko, Elena, Yardley, Denise A., De Boer, Richard H., Hurvitz, Sara A., Ejlertsen, Bent, Blau, Sibel, Ozguroglu, Mustafa, Landherr, Laszlo, Ewertz, Marianne, Taran, Tanya, Fan, Jenna, Noel-Baron, Florence, Louveau, Anne-Laure, Burris, Howard A.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Abstract PO1-04-02: ACE-Breast-03: A phase 2 study of ARX788, a novel next-generation anti-HER antibody-drug conjugate in HER2-positive metastatic breast cancer patients previously treated with trastuzumab deruxtecan
Ali, Kashif, Agrawal, Laila, Thummala, Anu, Kalinsky, Kevin, Ali, Sami, Blau, Sibel, Block, Margaret, Danso, Michael, Yardley, Denise, Andersen, Jay, Gropper-Waks, Adrienne, Jayachandran, Priya, Makhlin, Igor, Nikolinakos, Petros, O'Shaughnessy, Joyce, Aung, Sandra, Hessel, Colin, Rugo, Hope, Gradishar, William, Tripathy, Debu
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article
Abstract 2757: Using liquid biopsies and NGS as tools to analyze mutation burden and copy number variation in the blood of a patient with triple negative breast cancer to better inform therapeutic targets
Howard, Kellie, Kruse, Kimberly, Greenwood, Brianna, Swanson, Elliott, Ehrich, Mathias, Ellison, Christopher K., Jensen, Taylor, Austin, Sharon, Ramirez, Arturo, Boles, Debbie, Pruitt, John, Mahen, Elisabeth, Stilwell, Jackie L., Kaldjian, Eric P., Dorschner, Michael, Blau, Sibel, Eisenberg, Marcia, Anderson, Steve, Madan, Anup
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Get full text
Journal Article